PODD

Insulet Corporation (PODD)

Healthcare • NASDAQ$148.88+3.46%

Key Fundamentals
Symbol
PODD
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices
Price
$148.88
Daily Change
+3.46%
Market Cap
$10.10B
Trailing P/E
33.98
Forward P/E
18.04
52W High
$354.88
52W Low
$140.63
Analyst Target
$242.43
Dividend Yield
N/A
Beta
1.13
About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the ri

Company website

Research PODD on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...